Impact of delayed graft function on cadaveric kidney transplant outcome.
Gentil
M A
MA
Department of Nephrology, Hospital Universitario Virgen del Rocio, Sevilla, Spain.
Alcaide
M P
MP
Algarra
G R
GR
Pereira
P
P
Toro
J
J
González-Roncero
F
F
López
M
M
Bernal
G
G
Mateos
J
J
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002102:Cadaver; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D015999:Multivariate Analysis; D011183:Postoperative Complications / Q000145:classification / Q000453:epidemiology / Q000503:physiopathology; D011237:Predictive Value of Tests; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies; D013997:Time Factors; D014019:Tissue Donors; D016896:Treatment Outcome
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D001379:Azathioprine; D011241:Prednisone